Regulation of platelet count by erythropoiesis-stimulating agents – iron axis in hemodialysis patients

Higher doses of erythropoiesis-stimulating agents (ESAs) contribute to atherothrombotic cardiovascular disease in hemodialysis (HD) patients. Thrombocytosis is associated with increased mortality in ESA-treated HD patients. We investigated variables affecting platelet count and its variability (plat...

Descripción completa

Detalles Bibliográficos
Autores principales: Koike, Kiyomi, Fukami, Kei, Kawaguchi, Atsushi, Shimamatsu, Kazumasa, Yamagishi, Sho-ichi, Okuda, Seiya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4822794/
https://www.ncbi.nlm.nih.gov/pubmed/27099526
http://dx.doi.org/10.2147/IJNRD.S98196

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4822794/
https://www.ncbi.nlm.nih.gov/pubmed/27099526
http://dx.doi.org/10.2147/IJNRD.S98196

Ejemplares similares